NCI Pediatric MATCH Study Shows High Rate of Targetable Molecular Alterations in Tumor Specimens
A high percentage of patients with CNS tumors had disease characterized by an actionable molecular alteration.
General Oncology
Private Insurers Pay 241 Percent of What Medicare Would Pay
Prices paid to hospitals for privately insured patients in 2017 averaged 241 percent of what Medicare would have paid.
Cannabis Legalization Not Tied to Higher Health Care Utilization
Legalization of recreational cannabis is not associated with changes in health care utilization, as measured by length of stay or health care costs.
Barriers to Cancer Clinical Trial Enrollment
This fact sheet discusses potential barriers to participation in cancer clinical trials.
FDA Panel Backs Pexidartinib for Rare Tumor, Votes Against Quizartinib for FLT3-ITD AML
The Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee recently voted on 2 investigational therapies being developed by Daiichi Sankyo: pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT), and quizartinib for the treatment of adults with relapsed/refractory FLT3-ITD acute myeloid leukemia (AML).
Risk for Cancer Increased in Men, Women With T2DM
Standardized incidence ratio highest for prostate cancer for men, nasopharynx cancer for women.
News Is Good and Bad for Oncology Patient Navigation Studies
A systematic review of studies had surprising findings on the efficacy of oncology patient navigation.
In-House or Centralized Testing? Debating Whether Genomic Sequencing Is Best Conducted at Home
Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach?
ESMO Releases Recommendations on MSI Testing for Immunotherapy
“Molecular tests guarantee the highest values of specificity and sensitivity in MSI testing,” according to researchers.
Higher Risk for Cancer, Mortality Seen With Pediatric-Onset IBD
Individuals with pediatric-onset inflammatory bowel disease (pIBD) have an increased risk for cancer and mortality.
Next post in Pediatric Cancer
